Compass Therapeutics to Participate in Upcoming Investor Events

2 weeks ago

BOSTON, Sept. 03, 2024 ( GLOBE NEWSWIRE ) -- Compass Therapeutics, Inc. ( Nasdaq: CMPX ) , a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the ...

Ticker	Sentiment	Impact
CMPX	Neutral	64 %